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Abstract
Background: The use of autogenous bone chips during guided bone regeneration procedures has remained the
gold standard for bone grafting due to its excellent combination of osteoconduction, osteoinduction and
osteogenesis. Recent protocols established by our group have characterized specific growth factors and cytokines
released from autogenous bone that have the potential to be harvested and isolated into bone conditioned media
(BCM). Due to the advantageous osteo-promotive properties of BCM, the aims of the present study was to pre-coat
collagen barrier membranes with BCM and investigate its effect on osteoblast adhesion, proliferation and
differentiation for possible future clinical use.
Methods: Scanning electron microscopy (SEM) was first used to qualitative assess BCM protein accumulation on
the surface of collagen membranes. Thereafter, undifferentiated mouse ST2 stromal bone marrow cells were seeded
onto BioGide porcine derived collagen barrier membranes (control) or barrier membranes pre-coated with BCM
(test group). Control and BCM samples were compared for cell adhesion at 8 h, cell proliferation at 1, 3 and 5 days
and real-time PCR at 5 days for osteoblast differentiation markers including Runx2, alkaline phosphatase (ALP),
osteocalcin (OCN) and bone sialoprotein (BSP). Mineralization was further assessed with alizarin red staining at
14 days post seeding.
Results: SEM images demonstrated evidence of accumulated proteins found on the surface of collagen
membranes following coating with BCM. Analysis of total cell numbers revealed that the additional pre-coating
with BCM markedly increased cell attachment over 4 fold when compared to cells seeded on barrier membranes
alone. No significant difference could be observed for cell proliferation at all time points. BCM significantly
increased mRNA levels of osteoblast differentiation markers including ALP, OCN and BSP at 5 days post seeding.
Furthermore, barrier membranes pre-coated with BCM demonstrated a 5-fold increase in alizarin red staining at
14 days.
Conclusion: The results from the present study suggest that the osteoconductive properties of porcine-derived
barrier membranes could be further improved by BCM by significantly increasing cell attachment, differentiation
and mineralization of osteoblasts in vitro. Future animal testing is required to fully characterize the additional
benefits of BCM for guided bone regeneration.
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Background
The use of barrier membranes has commonly been uti-
lized in guided tissue regeneration (GTR) and guided
bone regeneration (GBR) procedures to selectively direct
the growth and repopulation of bone and periodontal
tissues from faster growing soft tissues [1, 2]. A variety
of biomaterials have been used to achieve this role with
much of their development occurring in the early 1980s
[3, 4]. Such materials should ideally facilitate cell recruit-
ment and attachment of both soft and hard tissue cells,
increase cell proliferation, and induce differentiation to-
wards their specific tissue types [5–8]. While GTR and
GBR techniques were first introduced using bio-inert,
non-resorbable expanded polytetrafluoroethylen mem-
branes (ePTFE), more recently resorbable collagen mem-
branes have been used due to the commonly reported
problems of ePTFE including the requirement for a sec-
ond surgery to remove the barrier, increased patient
morbidity, additional surgical costs and increased possi-
bility of bacterial colonization [9, 10]. The second gener-
ation of barrier membranes (resorbable membranes) are
commonly fabricated from porcine collagen I and III
and have demonstrated similar clinical results when
compared to ePTFE without the requirement of a sec-
ond surgery [11–15].
Third generation barrier membrane protocols now in-
clude their combination with a variety of growth factors
including bone morphogenetic proteins (BMPs), platelet-
derived growth factor (PDGF), enamel matrix derivative
(EMD) or fibroblast growth factor-2 (FGF2) [16–20].
While additional growth factor utilization do incur fur-
ther costs to the patient, numerous reports have demon-
strated their effectiveness in select cases where
limitations in defect anatomy could additionally necessi-
tate the use of potent growth factor to facilitate wound
healing and regeneration of tissues [16–20].
Recently our laboratory has been highly interested in
discovering the key elements of autogenous bone grafts
that make them so favorable for bone augmentation pro-
cedures [21]. Initial experiments revealed that harvesting
with a variety of different surgical techniques could sig-
nificantly alter the survival of bone cells as well as their
release of growth factors [22, 23]. These preliminary
studies revealed a tight regulation over the control of
factors being released to the surrounding media as well
as their potential to either induce or resorb surrounding
bone.
The second series of experiments focused mainly on
harvesting these factors in something now termed ‘bone
conditioned medium’ (BCM) and discovering if these
factors alone could influence cell behaviour [22, 24–28].
Here, the primary focus was to test the efficacy of BCM
on a variety of cell types demonstrating that the BCM
medium serves as a strong inducer of the TGF-beta cell
activity responsible for the differentiation of various cell
types. Simply stated, fresh bone chips contain viable
cells, mainly osteocytes capable of controlling bone re-
modeling through a variety of growth factor proteins
that induce gene expression in mesenchymal progenitor
cells [24–26, 28]. Therefore, the possibility exists that
collection released growth factors from autogenous bone
(bone-conditioned media) over a period of time followed
by re-delivery to subsequent cells/tissues may potentially
be a source of autogenous growth factor delivery specific
for ideal bone regeneration.
To date, no study has yet to investigate the influence
of BCM in combination with collagen barrier mem-
branes on osteoblast behaviour. As common growth fac-
tor delivery vehicles include collagen barrier membranes
due to their advantageous adsorption of growth factors,
the aim of the present study was to investigate the com-
bination of barrier membranes pre-coated with BCM as
a possible growth factor source derived from autogenous
source. The effect of BCM in combination with barrier
membranes was tested on osteoblast adhesion, prolifera-
tion and differentiation in vitro.
Methods
BCM and barrier membranes
Bone was obtained from adult pigs (Metzgerei Balsiger,
Wattenwil, Switzerland) and harvested from the buccal-
sided mandibular cortical bone with a “bone scraper”
(Hu-Friedy, Rotterdam, Netherlands) and placed into
sterile plastic dishes as previously described [26]. An in
vivo ethical approval was not necessary as the animals
were euthanized at the local butcher for non-scientific
reasons and thereafter the bone samples were immedi-
ately collected and transported for use in this study.
BCM was harvested by placing 10 mL of culture media
with 10 g of autogenous bone chips. After 24 h of incu-
bation at 37 °C in a humidified atmosphere and 5 % car-
bon dioxide, BCM was filtered sterile and kept frozen at
−80 °C and thawed during experimental cell seeding as
previously described [26]. For all in vitro cell experi-
ments, membranes were loaded with 20 % BCM at
time point 0 for 5 min. Membranes were incubated
for 5 min with BCM based on our group’s previous
investigation that found that an adsorption plateau of
growth factors occurred roughly around 5 min [29].
Afterwards, routine cell culture media was utilized. A
porcine derived collagen barrier membrane (BioGide,
Geistlich, Switzerland) was utilized as the material of
choice for the present study due to our laboratories
previously handling with its use [30]. For in vitro ex-
periments, barrier membranes were cut and placed in
the bottom of 24 well dishes and thereafter coated
with BCM for 5 min prior to cell seeding.
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Cell culture system
Undifferentiated mouse cell-line ST2 stromal bone mar-
row cells were used for this study.
Cells were detached from the tissue culture plastic
using trypsin solution. During cell seeding for differenti-
ation experiments, α-MEM medium (Invitrogen, Basel,
Switzerland) was supplemented with 50 μg/ml ascorbic
acid (Invitrogen) and 2 mM β-glycerophosphate (Invitro-
gen) to promote osteoblast differentiation as previously
described [23]. Osteoblasts were seeded at a density of
10,000 cells in 24 well culture plates for cell adhesion
and proliferation experiments and 50,000 cells per well
in 24 well dishes for real-time PCR and alizarin red ex-
periments. For experiments lasting longer than 5 days,
medium was replaced twice weekly.
Adhesion and proliferation assay
Osteoblasts were seeded in 24-well plates at a density of
10,000 cells per well either control barrier membranes
or barrier membranes + BCM. Cells were quantified
using fluorescent MTS assay (Invitrogen) at 8 h for cell
adhesion and 1, 3 and 5 days for cell proliferation as pre-
viously described [30]. At desired time points, cells were
washed with phosphate buffered solution (PBS) and
quantified using a fluorescence plate reader (Infinite 200,
Tecan Group Ltd. Männedorf, Switzerland). Experi-
ments were performed in triplicate with three independ-
ent experiments for each condition. Means and standard
deviations (SE) were calculated, and the statistical sig-
nificance of differences was examined by student t-test
between both groups for cell adhesion (*, p values < 0.05
was considered significant). Data for cell proliferation
were analyzed for statistical significance using two-way
analysis of variance with Bonferroni test (*, p values <
0.05 was considered significant).
Real-time PCR for differentiation markers
Real-time RT-PCR was used to investigate the expression
of genes encoding osteoblast differentiation markers. Total
RNA was isolated using High Pure RNA Isolation Kit
(Roche, Switzerland) at 5 days for osteoblast differenti-
ation markers. Primer and probe sequences for genes en-
coding alkaline phosphatase (ALP), runt-related
transcription factor 2 (Runx2), osteocalcin (OCN), bone
sialoprotein (BSP) and glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) were fabricated with Primer se-
quences according to Table 1. Real-time RT-PCR was
performed using Roche Master mix and quantified on an
Applied Biosystems 7500 Real-Time PCR Machine. All
samples were assayed in duplicate with 3 independent ex-
periments were performed. The ΔΔCt method was used
to calculate gene expression levels normalized to GAPDH
values and calibrated to control samples. Means and
standard deviations (SE) were calculated, and the
statistical significance of differences was examined by stu-
dent t-test between both groups (*, p values < 0.05 was
considered significant).
Alizarin red staining
Alizarin red staining was performed to determine the
presence of extracellular matrix mineralization. After
14 days, cells were fixed in 96 % ethanol for 15 min and
stained with 0.2 % alizarin red solution (Sigma Aldrich)
in water (pH 6.4) at room temperature for 1 h as previ-
ously described [23]. Alizarin red staining was performed
using images captured on a Nikon D610 camera with a
Heerbrugg M400 ZOOM microscope (WILD HEER-
BRUGG, Switzerland). Image J software was used to
quantify data using set parameters for colour intensity
staining of red using color threshold including parame-
ters for hue, saturation and brightness. The same thresh-
old values were used for all analyzed. Means and
standard deviations (SE) were calculated, and the statis-
tical significance of differences was examined by one-
way analysis of variance with Bonferroni test (*, p values
< 0.05 was considered significant).
Results
Influence of BCM on surface coating, osteoblast adhesion
and proliferation
First, SEM was utilized to investigate the influence of
pre-coating BCM onto collagen membranes for varia-
tions in surface topography/protein coating (Fig. 1).
While control barrier membranes demonstrated many
collagen fibrils found on their surface (Fig. 1a, b), the
additional coating with BCM revealed the presence of
accumulated proteins found on the surface of the barrier
membrane (Fig. 1d, arrows), when compared to control
samples at high magnification (Fig. 1c). Thereafter, the
effects of BCM were investigated on cell adhesion of os-
teoblasts to barrier membranes. It was found that coat-
ing BCM onto barrier membranes significantly enhanced
Table 1 PCR primers for genes encoding Runx2, ALP, BSP, OCN
and GAPDH
Gene Primer sequence
mRUNX2 F agggactatggcgtcaaaca
mRUNX2 R ggctcacgtcgctcatctt
mBSP F gcatcgaagagtcaaaatag
mBSP R ttcttctccattgtcttctc
mALP F ggacaggacacacacacaca
mALP R caaacaggagagccacttca
mOCN F cagacaccatgaggaccatc
mOCN R ggactgaggctctgtgaggt
mGAPDH F aggtcggtgtgaacggatttg
mGAPDH R tgtagaccatgtagttgaggtca
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over 5 fold the number of attached osteoblasts 8 h post
seeding when compared to uncoated control barrier
membranes (Fig. 2). The effects of BCM however dem-
onstrated no effect on osteoblast proliferation as quanti-
fied by an MTS assay at 1, 3 and 5 days post seeding
(Fig. 3).
Influence of BCM on osteoblast gene expression and
mineralization
The addition of BCM to collagen barrier membranes
was then investigated on osteoblast differentiation. Real-
time PCR for genes encoding Runx2 demonstrated no
influence of BCM when combined with a barrier mem-
brane (Fig. 4a). In contrast, pre-coating BCM onto
barrier membranes significantly increased mRNA levels
of ALP (Fig. 4b), OCN (Fig. 4c) and BSP (Fig. 4d) at
5 days post seeding (p < 0.05). Furthermore, alizarin red
staining was used to quantify in vitro mineralization
(Fig. 5). It was found that barrier membranes pre-coated
with BCM revealed a 5-fold increase in alizarin red
staining when compared to control barrier membranes
as well as barrier membranes pre-coated with BCM
without cells (negative control) (Fig. 5).
Discussion
The aim of the present study was to investigate the po-
tential benefits of pre-coating BCM onto barrier mem-
branes on the in vitro cell behaviour of bone-forming
osteoblasts. To date, no study has investigated the po-
tential of BCM on osteoblast differentiation when com-
bined with a biomaterial. Therefore, in light of these
recent findings by our group demonstrating the effects
of BCM, it was hypothesized that BCM could be used as
Fig. 1 SEM images of control collagen barrier membranes at (a) 50X and (b) 400 X magnification. The additional coating of BCM onto collagen
membranes increased surface protein accumulation (d, arrows 1600X magnification) when compared to control samples (c, 1600X magnification)
Fig. 2 Attachment assay of ST2 osteoblasts seeded on control
barrier membranes in comparison to membranes + BCM. The
combination of barrier membranes with BCM significantly
upregulated osteoblast attachment onto barrier membranes at 8 h
post seeding (* denotes significant difference, p < 0.05)
Fig. 3 Proliferation assay of ST2 osteoblasts seeded on control
barrier membranes and barrier membranes with BCM at 1, 3 and
5 days post seeding. No significant difference could be observed
between treatment samples
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a potential autogenous growth factor source derived spe-
cifically from bone tissues for bone regeneration.
Several studies by our group have extensively investi-
gated in vitro cell behavior in response to BCM. In these
studies, cortical bone chips obtained from porcine man-
dibles were collected using a bone scraper and incubated
in cell culture medium for 24 h to allow growth factor
accumulation [31]. Initial experiments were designed to
investigate contained proteins within BCM via proteo-
mics analysis. It was found that more than 40 different
growth factors and extracellular matrix molecules were
found released from bone chips into BCM; known fac-
tors capable of inducing osteoblast and osteoclast activ-
ity [32, 33]. Analysis of the entire genome for cells
cultured with BCM indicated that BCM serves as a
strong inducer of TGF-beta dependent pathways by sig-
nificantly altering the expression of IL11, IL33, ADM,
NOX4, PRG4, and PTX3 [34]. Based on these novel
findings demonstrating the effects of BCM on TGF-beta
dependent pathways in gingival fibroblasts [34], it was
hypothesized that BCM could potentially induce the ac-
tivity of osteoblast progenitor cells towards mineral-
producing mature osteoblasts, specifically when coated
in combination with a collagen barrier membrane.
It was found that BCM significantly upregulated the
adhesion of osteoblasts to barrier membranes over 5 fold
Fig. 4 Real-time PCR of osteoblasts seeded on control barrier membranes and barrier membranes pre-coated with BCM for genes encoding (a)
Runx2, (b) alkaline phosphatase (ALP), (c) osteocalcin (OCN) and (d) bone sialoprotein (BSP) at 5 days post seeding (* denotes significant
difference, p < 0.05)
Fig. 5 Alizarin red staining at 14 days on (1) control barrier membranes
without ST2 cells, (2) barrier membranes pre-coated with BCM without
ST2 cells, (3) ST2 cells on control barrier membranes and (4) ST2
cells on barrier membranes pre-coated with BCM. Semi-quantified
evaluation of alizarin red staining. Pre-coating collagen membranes
with BCM significantly increased alizarin red staining as assessed
by colour thresholding software (* denotes significantly higher
compared with the other modalities, p < 0.05)
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when compared to non-coated membranes (Fig. 2). As it
is known that cells need to bind to biomaterials through
extra-cellular matrix proteins, the present study hypoth-
esized that certain proteins found in BCM contain cell
adhesion domains able to enhance cell attachment of
mesenchymal cells. Future investigation regarding cell-
protein binding sites in response to BCM remains to be
characterized. Furthermore, analysis of various integrin-
binding domains could prove strategic to further
characterize the responsible proteins found in BCM cap-
able of facilitating cell attachment to biomaterials that
are pre-coated with growth factors from an autogenous
bone source.
Results from the present study also confirm that BCM
is able to significantly increase gene expression of BSP
and OCN, known markers of osteoblast differentiation.
While the significant increase was observed at 1.5 times
control values, alizarin red staining revealed a 5-fold en-
hancement in staining intensity when collagen mem-
branes were pre-coated with BCM. Thus, it may be
hypothesized that the accumulated proteins contained
within BCM may possess the potential to speed in vivo
bone formation due to its influence on cell behavior in
vitro. Future investigation regarding the potential use of
BCM for a clinical setting remains to be investigated.
Two key questions remain unanswered from the
present study. First, the stock BCM utilized in the
present study was collected from cell culture media with
bone chips over a period of 24 h. The potential use of
BCM for clinical application would require a markedly
shorter time period for growth factor accumulation. An
average implant procedure last roughly 30 to 60 min
[35] and would ideally be the maximum time required
to accumulate enough growth factors for possible use.
Thus it remains to be investigated if the concentration
obtained from this short period would be enough to
maintain its influence on differentiation towards bone-
forming osteoblasts. Furthermore, at presence it is un-
known what effect the concentration of BCM might
have on hard tissue formation in vivo. For instance, it is
well known that recombinant proteins necessitate very
higher concentrations in vivo when compared to in vitro
studies [30]. It remains to be investigated what the ideal
concentration for in vivo use and potentially additional
methods to further concentrate BCM for further clinical
utilization as an autogenous growth factor source specif-
ically derived from bony tissues.
Conclusion
The results from the present study demonstrate that
pre-coating collagen barrier membranes with BCM
significantly increased osteoblast attachment when
compared to barrier membranes alone. Furthermore,
pre-coating collagen membranes with BCM enhanced
osteoblast differentiation and mineralization as assessed
by real-time PCR and alizarin red staining. The combin-
ation of these findings suggests that BCM may be a valu-
able method to collect bone-derived growth factors from
autogenous source for future biomaterial coating. Future
experiments to determine the optimal culturing period,
optimal carrier system as well as assessment of new
bone formation in an animal model are now necessary
to further investigate the clinical potential of BCM.
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